OPKO Health's BioReference Laboratories Launches COVID-19 Testing Program for New York City Schools Oct 9, 2020
Pfizer Announces Positive Phase 3 Top-line Results for Once-Weekly Investigational Long-Acting Human Growth Hormone to Treat Children with Growth Hormone Deficiency Oct 8, 2020
OPKO Health's BioReference Laboratories Announces New York City Schools COVID-19 Testing Program Sep 2, 2020
OPKO Health's BioReference Laboratories Launches Best-in-Class Next-Generation Sequencing (NGS) Assay Sep 1, 2020
OPKO Health’s GeneDx Enters into Agreement with Pediatrix Medical Group to Offer Neonatal Genomic Services Aug 12, 2020
